Found 7 matching trials
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation
PHASE2Viral infections can profoundly influence alloimmune responses and hamper a...
Location
Hospital Clinic Barcelona, University of Barcelona
Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
PHASE4Current therapy to prevent organ rejection relies on the use of calcineurin...
Location
Buffalo General Hospital Multi-Organ Transplant Department
Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance
NAImmunosuppressive drugs can be successfully withdrawn in a fraction of live...
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
PHASE2The primary aim of this study is to determine whether a peripheral blood or...
Location
University of California, San Francisco Medical Center
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
PHASE1Antirejection medicines, also known as immunosuppressive drugs, are prescri...
Location
University of California, San Francisco
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
PHASE2In order to prevent organ rejection, patients receiving liver transplants c...
Location
University of California, San Francisco
Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance
PHASE2In liver transplantation up to 20% of recipients can completely discontinue...
Location
Hospital Clinic Barcelona, University of Barcelona